--- title: "Allient Q2 2026 Earnings: Record Gross Margin Lifts Profitability" type: "News" locale: "en" url: "https://longbridge.com/en/news/295024393.md" description: "Allient (Nasdaq: ALNT) reported Q2 2026 revenue of $153.8 million, up 10% year-over-year, with diluted EPS rising to $0.61 from $0.34. Gross margin hit a record 34.9%, driven by volume growth and operational improvements. Orders surged 49% to $201.3 million, expanding the backlog to $298.0 million. While net income grew 85%, operating cash flow declined due to working capital investments in receivables and inventory. The company provided full-year 2026 guidance for capital expenditures and restructuring costs." datetime: "2026-08-05T22:25:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295024393.md) - [en](https://longbridge.com/en/news/295024393.md) - [zh-HK](https://longbridge.com/zh-HK/news/295024393.md) --- # Allient Q2 2026 Earnings: Record Gross Margin Lifts Profitability Allient (Nasdaq: ALNT) reported Q2 2026 revenue of $153.8 million, up 10% from $139.6 million a year earlier, while diluted EPS rose to $0.61 from $0.34. For the quarter ended June 30, gross margin reached a record 34.9%, and orders grew substantially faster than revenue, lifting backlog to $298.0 million. ## Core earnings data Reported revenue growth included a favorable $1.3 million currency effect. On the company’s non-GAAP organic basis, which excludes currency and acquisition effects, revenue increased 9.3%. Profit grew faster than revenue as higher volume, improved product mix and operational improvements under the Simplify to Accelerate NOW initiative expanded margins. Lower interest expense and a lower effective tax rate also supported net income. Metric Q2 2026 Q2 2025 Year-over-year change Revenue $153.8 million $139.6 million +10.2% Gross profit and margin $53.6 million; 34.9% $46.4 million; 33.2% Margin +170 bps Operating income and margin $15.6 million; 10.2% $11.7 million; 8.4% Margin +180 bps Net income $10.4 million $5.6 million +85% Diluted EPS $0.61 $0.34 +$0.27 Adjusted diluted EPS $0.80 $0.57 +$0.23 Adjusted EBITDA and margin $23.7 million; 15.4% $20.1 million; 14.4% Margin +100 bps Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures. Operating expenses increased to $38.0 million from $34.7 million, but declined slightly as a percentage of revenue to 24.7%. Higher commissions, personnel costs, incentive compensation and sales and marketing expenses accounted for the dollar increase. ## Business and market performance Industrial and Aerospace & Defense produced the fastest growth, while Medical also expanded. Vehicle revenue and distribution-channel sales declined, creating a clear difference between Allient’s growth markets and its weaker powersports and channel exposure. Market or channel Year-over-year change Company-disclosed driver Industrial +17% Industrial automation, data center infrastructure and critical facility applications Aerospace & Defense +16% Program timing and defense demand tied to mission-critical platforms Medical +9% Surgical precision motion and pumps for life sciences and healthcare Vehicle \-7% Lower powersports demand, partly offset by commercial automotive growth Distribution channel \-6% Normal variability in channel ordering patterns Sales to U.S. customers represented 54% of revenue, compared with 55% a year earlier, with the remainder generated primarily in Europe, Canada and Asia-Pacific. ## Orders outpaced revenue and expanded backlog Orders reached a record $201.3 million, up 49% year over year and 27% sequentially. Because orders exceeded quarterly revenue, the book-to-bill ratio rose to 1.31x, with the strongest demand improvements coming from Industrial and Aerospace & Defense. Backlog ended the quarter at $298.0 million, up from $251.0 million at March 31, 2026. Management expects most of the backlog to convert into revenue within three to nine months, making execution and shipment timing important indicators for the second half of 2026 and early 2027. ## Working capital investment reduced cash conversion despite higher earnings The cash-flow figures cover the first six months of 2026 rather than Q2 alone. Six-month operating cash flow fell to $20.1 million from $38.4 million even as six-month net income increased to $15.7 million from $9.2 million. The difference primarily reflected receivables timing and inventory investments intended to support growth and secure critical materials amid supply constraints. At June 30, trade receivables were $99.8 million, up from $88.8 million at year-end, while inventories increased to $117.9 million from $109.2 million. First-half capital expenditures also rose to $7.1 million from $3.2 million as Allient invested in capacity, technology and productivity. Management expects working capital to normalize as inventory and backlog convert into revenue and cash. Cash and cash equivalents were $42.1 million at quarter-end. Total debt declined by $4.0 million during Q2 to $173.3 million, while the company-defined leverage ratio improved to 1.63x. Net debt was $131.2 million, and Allient had $162.0 million of unused revolving-credit capacity. ## 2026 guidance Allient provided full-year expectations for capital spending, restructuring costs and its effective tax rate. These ranges indicate continued investment in capacity and the Dothan transition while framing the associated cash and expense requirements. Metric Full-year 2026 guidance Context Capital expenditures $12.0 million to $15.0 million Capacity, technology and productivity investments Restructuring and business realignment costs $2.0 million to $3.0 million Includes costs associated with the Dothan transition Effective income tax rate 21% to 23% Compared with 20.2% in Q2 2026 ## Recent insider transactions The supplied insider records show that most of the latest activity consisted of stock awards rather than open-market transactions. The clearest sale was General Counsel Ashish Bendre’s disposition of 6,000 shares for $378,000; the transaction alone does not establish an insider view of the company’s prospects. Date Insider Role Transaction Reported amount June 4, 2026 Robert B. Engel Director Stock gift $0 reported value May 6, 2026 Richard D. Federico Director Stock award $31,086 at $77.52 per share May 6, 2026 Ashish Bendre General Counsel Stock award $31,241 at $77.52 per share March 27, 2026 Ashish Bendre Officer Sale 6,000 shares at $63.00; $378,000 March 5, 2026 Richard S. Warzala CEO Stock award $2,369,584 at $62.07 per share ## Risks investors should monitor - **Working-capital pressure:** Receivables and inventory absorbed cash during the first half. Delays in converting these assets into sales and collections could keep operating cash flow below earnings. - **Backlog execution and supply constraints:** The larger backlog supports revenue visibility, but realizing that benefit depends on production, material availability and shipments occurring within the expected three-to-nine-month period. - **Uneven end-market demand:** Vehicle revenue declined because of weaker powersports demand, while distribution sales fell due to variable channel ordering. Continued weakness could offset some growth in Industrial and Aerospace & Defense. - **Restructuring and transition execution:** Carryover costs from the Dothan transition remained elevated, and full-year restructuring and realignment costs are expected to reach $2 million to $3 million. - **Higher operating investment:** Personnel, incentive compensation, sales and marketing expenses increased with growth. Those costs could weigh on operating leverage if revenue momentum slows. ## Summary Allient’s Q2 2026 results combined double-digit reported revenue growth with record gross margin and faster earnings growth, supported by Industrial, Aerospace & Defense and Medical demand. Record orders and higher backlog strengthen forward revenue visibility, but investors should watch whether backlog and inventory convert into cash as expected, whether current margins hold, and how effectively Allient completes its restructuring and capacity investments. Find out more ### Related Stocks - [ALNT.US](https://longbridge.com/en/quote/ALNT.US.md) ## Related News & Research - [Allient CEO Richard Warzala disposes of common shares worth $9.09 million](https://longbridge.com/en/news/295712422.md) - [Allient Q2 revenue beats estimates on industrial automation, data center growth](https://longbridge.com/en/news/295010989.md) - [Flexsteel Q4 2026 Earnings Preview](https://longbridge.com/en/news/296031749.md) - [Algorhythm Holdings Reports Second Quarter 2026 Financial Results](https://longbridge.com/en/news/296124832.md) - [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/296129742.md)